Back to mobile site

Abiomed, Inc. (ABMD) Tops Q2 EPS by 15c

November 1, 2012 7:17 AM EDT
Abiomed, Inc. (NASDAQ: ABMD) reported Q2 EPS of $0.20, $0.15 better than the analyst estimate of $0.05. Revenue for the quarter came in at $37.4 million versus the consensus estimate of $37.47 million.

For earnings history and earnings-related data on Abiomed, Inc. (ABMD) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings